Q3 15 in Review Adjusted EPS of 0.29, in-line with our expectations; Notable new business & partnership Yosemite American Heart Association; Productivity acceleration in North America; Margin expansion and growth in FSS Intl &…
Capital Structure Review Liquidity is strong Cash and revolver availability 600M No significant maturities until 2019; Expect capex of 3.25% 3.50% of sales for FY15; As anticipated, YTD FCF significantly improved +140M vs. PY;…
Business Outlook Unchanged 2H expectations vs. prior year unchanged Adjusted EPS 1.50 to 1.60 AOI increase expected in Q4; VS Prior Year 2H Revenue AOI FSS NA FSS Intl Uniform ARMK 8
Summary Q3 in-line & 15 outlook reaffirmed; Solid fundamentals & right strategy; Productivity & margin capture; Encouraging outlook. 9
Appendix 10
Components of Underlying Growth Third Quarter 15 Underlying Sales Growth Q3 2015 % Change M Estimated Impact of Calendar Shift -2% (70) Estimated Impact of Large Account Nonrenewal -1% (36) Underlying Business Growth 3% 106…
Non-GAAP Reconciliation Selected Operational and Financial Metrics Adjusted Sales (Organic) Management believes that presentation of sales growth, adjusted to eliminate the effects of acquisitions and divestitures and the impact of…
Non-GAAP Reconciliation ARAMARK AND SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES ADJUSTED CONSOLIDATED OPERATING INCOME MARGIN (Unaudited) (In thousands) Third Quarter 15 Three Months Ended July 3, 2015 Aramark and…
Non-GAAP Reconciliation Third Quarter 15 Adjusted EPS Adjusted Net Income 14
Non-GAAP Reconciliation Third Quarter 15 Free Cash Flow Nine Months Nine Months (Unaudited) Ended Ended (in millions) Fiscal (in 2015 thousands) (inFiscal 2014 thousands) Net cash provided by (used in) operating activities…